Germany Takes Major Step Toward Adult-Use Cannabis Pilot Trials

Germany, once known for its cautious approach to cannabis, has steadily progressed toward a comprehensive legalization model. The nation’s journey—from strict prohibition to allowing limited home cultivation and personal possession—has paved the way for more ambitious measures. A major next step in Germany’s cannabis reform is the implementation of regional pilot trials to evaluate legal cannabis commerce. These trials represent part of the “second pillar” of the country’s adult-use legalization model and bring Germany closer to a fully regulated national cannabis marketplace.

From Prohibition to Legalization

Historically, cannabis faced decades of strict prohibition in Germany. Before recent reforms, consumption and possession triggered significant legal consequences. However, public sentiment began to shift, and by 2022, 61% of Germans favored regulated cannabis distribution, according to an Ipsos survey. That support set the stage for what would become the Cannabis Act (CanG), which took effect in phases starting April 1, 2024.

Key Milestones in Legalization:

• April 1, 2024 (Phase 1):
  • Cannabis removed from the country’s narcotics list.
  • Adults legally allowed to possess up to 25 grams of cannabis.
  • Home cultivation permitted—up to three flowering plants and a household limit of 50 grams of cannabis.
• July 1, 2024 (Phase 2):
  • Member-based cultivation associations (akin to Cannabis Social Clubs) permitted to supply cannabis to adults under strict regulations.
  • On-site consumption and direct retail sales remain off-limits at this stage.

Germany’s cautious, step-by-step strategy reflects the government’s intention to balance adult freedoms with public health considerations. Consumption in public is legal, yet restricted near schools, playgrounds, and other child-centered areas.

Controlled Legalization to Combat the Black Market

The German government’s decision to legalize cannabis for adults stems from the realization that prohibition had failed to deter use or eradicate the illicit market. Under the old model, the black market thrived, and consumers were often exposed to unsafe, contaminated products with unknown THC levels. By bringing cannabis above-ground, German lawmakers aim to:

• Improve consumer safety with tested, quality-controlled products.
• Weaken organized crime by eliminating black-market demand.
• Expand health education and substance abuse prevention efforts.

German Health Minister Karl Lauterbach has described the reforms as a “long-term turnaround in drug policy,” aiming for a regulated system that avoids pitfalls observed elsewhere.

Federal Office for Agriculture and Food Takes the Helm

In a recent development, Germany assigned the Federal Office for Agriculture and Food (BLE) to oversee research projects and pilot trials related to consumer cannabis and industrial hemp. Previously, this role fell under the Federal Institute for Drugs and Medical Devices (BfArM), which still supervises research into medical cannabis. By shifting regulatory responsibilities, Germany is streamlining its approach to gathering scientific data on adult-use cannabis and ensuring that policy decisions are grounded in evidence.

“By passing the Consumer Cannabis Act, the Bundestag gave the Federal Ministry of Food and Agriculture (BMEL) the task of appointing the responsible body for processing research applications,” stated German officials. With the Consumer Cannabis Science Responsibility Regulation now in place, the BLE will review and approve research proposals, ensuring that pilot projects meet quality standards and align with health, safety, and youth protection goals.

Beyond Home Cultivation: The Path to Pilot Trials

The upcoming pilot trials will allow participating regions to test regulated cannabis commerce. This “second pillar” focuses on legal retail distribution through specialty stores, complementing the “first pillar” of home cultivation and member-based cultivation associations.

However, the path isn’t entirely clear yet. Additional regulatory steps and detailed legislation are required before the pilot trials can be fully rolled out. The Federal Ministry of Health will draft a comprehensive law to govern the nationwide testing of cannabis specialty stores. Until then, research into consumer cannabis will require special permits, and potential participants—universities, private companies, and other institutions—must meet stringent criteria to obtain approval.

Medical Cannabis and the Legacy of Hemp

Germany’s cannabis landscape isn’t defined solely by the adult-use market. The country has had a medicinal cannabis framework since 2017, making it one of Europe’s largest medical cannabis markets. Initially reliant on imports, Germany has begun cultivating its own medicinal cannabis, improving the consistency of supply for patients. Around two-thirds of health insurance companies now cover cannabis prescriptions under specific conditions—though securing a prescription can still be challenging.

Meanwhile, industrial hemp, once banned in 1982, has been allowed since 1996. Although hemp production fluctuated over the decades, today Germany is among Europe’s top five growers. Hemp’s revival reflects a broader acceptance of the cannabis plant’s potential—from wellness to sustainability.

Historical Roots and Changing Attitudes

Cannabis in Germany dates back thousands of years. Archaeological evidence shows cannabis seeds were used as far back as 7,500 years ago in what is now central Germany. By the Middle Ages, cannabis was widely recognized for its medicinal properties, with texts from the 12th century praising its therapeutic benefits. While prohibition temporarily pushed cannabis into the shadows in the 20th century, cultural acceptance and scientific interest have resurged in recent years.

Now, the majority of Germans support the new path, recognizing that well-regulated legalization can better protect public health and generate valuable data. With each legislative step, Germany is moving away from a purely prohibitionist stance and toward a regulated, evidence-based model that may inspire other European nations.

Looking Ahead

For now, Germany’s cannabis journey is very much a work in progress. The recent assignment of the BLE as the overseeing body for cannabis research and the ongoing rollout of pilot trials mark a pivotal moment. If successful, these steps could pave the way for legal cannabis retail stores and a thriving, regulated market.

As Germany refines its policies and builds on its historical experience, the nation’s careful, evidence-driven approach may become a blueprint for European cannabis legalization—creating a safer environment for consumers, curbing illicit trade, and ensuring that quality, education, and responsibility remain at the forefront.